Carbocisteine


Concise Prescribing Info
Indications/Uses
Excessive mucus or sputum.
Dosage/Direction for Use
Adult: PO Initial: 2,250 mg/day in divided doses, reduce to 1,500 mg/day when response is obtained.
Administration
Should be taken with food.
Contraindications
Active peptic ulceration. Children <2 years.
Special Precautions
Patient with history of gastroduodenal ulcers, bronchospasm, asthma or respiratory failure. Debilitated patients. Children ≥2 years. Pregnancy and lactation.
Adverse Reactions
Significant: Gastrointestinal bleeding. Rarely, urticaria and bronchospasm. Immune system disorders: Anaphylactic reactions, fixed drug eruption. Gastrointestinal disorders: Nausea, vomiting, diarrhoea, gastric discomfort. Respiratory, thoracic and mediastinal disorders: Bronchorrhea. Skin and subcutaneous tissue disorders: Rashes. Rarely, bullous dermatitis (e.g. Stevens-Johnson syndrome, erythema multiforme).
ATC Classification
R05CB03 - carbocisteine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.
Disclaimer: This information is independently developed by CIMS based on carbocisteine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in